tiprankstipranks
Advertisement
Advertisement

ALPMF Stock Latest News

Astellas Highlights R&D Strategy While Flagging Market and Development Risks
Company AnnouncementsAstellas Highlights R&D Strategy While Flagging Market and Development Risks
6d ago
Astellas and HOVON Phase 3 AML Trial for Xospata Misses Survival Goal
PremiumCompany Announcements
Astellas and HOVON Phase 3 AML Trial for Xospata Misses Survival Goal
28d ago
Astellas Flags Risks and Uncertainties Around Sustainability Plans and Pipeline
PremiumCompany Announcements
Astellas Flags Risks and Uncertainties Around Sustainability Plans and Pipeline
1M ago
Why Is Vir Biotechnology Stock Up Today?
PremiumMarket News
Why Is Vir Biotechnology Stock Up Today?
1M ago
VIR
Astellas Settles Myrbetriq Patent Disputes with Lupin and Zydus
PremiumCompany Announcements
Astellas Settles Myrbetriq Patent Disputes with Lupin and Zydus
2M ago
Astellas-Backed Bladder Cancer Trial Nears Key Data Moment After Study Completion
PremiumCompany AnnouncementsAstellas-Backed Bladder Cancer Trial Nears Key Data Moment After Study Completion
2M ago
ALPMF
Solid Near-Term Outperformance but Post-Xtandi Uncertainty Keeps Shares at Hold
Premium
Ratings
Solid Near-Term Outperformance but Post-Xtandi Uncertainty Keeps Shares at Hold
2M ago
Astellas Lifts FY2025 Outlook on Robust XTANDI and Mirabegron Demand
Premium
Company Announcements
Astellas Lifts FY2025 Outlook on Robust XTANDI and Mirabegron Demand
2M ago
ALPMF Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
ALPMF Upcoming Earnings Report: What to Expect?
2M ago
Astellas Targets Post‑Stroke Recovery With First‑in‑Human ASP2246 Study
PremiumCompany Announcements
Astellas Targets Post‑Stroke Recovery With First‑in‑Human ASP2246 Study
3M ago
ALPMF
Astellas Completes Key Menopause Drug Study in Japan, Setting Up Next Growth Phase for Fezolinetant
PremiumCompany Announcements
Astellas Completes Key Menopause Drug Study in Japan, Setting Up Next Growth Phase for Fezolinetant
3M ago
ALPMF
Astellas and Pfizer Unveil Breakthrough in Bladder Cancer Treatment
PremiumCompany Announcements
Astellas and Pfizer Unveil Breakthrough in Bladder Cancer Treatment
4M ago
Astellas Pharma Revises FY2025 Financial Forecasts Upward
PremiumCompany AnnouncementsAstellas Pharma Revises FY2025 Financial Forecasts Upward
5M ago
Astellas Pharma (ALPMF) Q2 Earnings Cheat Sheet
Premium
Pre-Earnings
Astellas Pharma (ALPMF) Q2 Earnings Cheat Sheet
5M ago
Astellas Pharma’s ASP4396 Study: A Potential Game-Changer for Solid Tumors
Premium
Company Announcements
Astellas Pharma’s ASP4396 Study: A Potential Game-Changer for Solid Tumors
5M ago
ALPMF
Astellas Pharma’s ASP3021 Study: A New Hope for AMD Patients?
PremiumCompany Announcements
Astellas Pharma’s ASP3021 Study: A New Hope for AMD Patients?
5M ago
ALPMF
Astellas Pharma’s Peficitinib Study: Key Insights for Investors
PremiumCompany Announcements
Astellas Pharma’s Peficitinib Study: Key Insights for Investors
5M ago
ALPMF
Astellas Pharma’s Innovative Bladder Device: A Game Changer in Urinary Health?
PremiumCompany Announcements
Astellas Pharma’s Innovative Bladder Device: A Game Changer in Urinary Health?
5M ago
ALPMF
Astellas Pharma’s Promising Phase 1 Study on ASP3082 for Advanced Solid Tumors
PremiumCompany Announcements
Astellas Pharma’s Promising Phase 1 Study on ASP3082 for Advanced Solid Tumors
5M ago
ALPMF
Astellas Pharma’s ASP5834 Study: A New Hope for KRAS Mutation Cancers
PremiumCompany AnnouncementsAstellas Pharma’s ASP5834 Study: A New Hope for KRAS Mutation Cancers
5M ago
ALPMF
Pfizer and Astellas Study on Prostate Cancer Treatment: Key Insights for Investors
Premium
Company Announcements
Pfizer and Astellas Study on Prostate Cancer Treatment: Key Insights for Investors
5M ago
PFE
Astellas Pharma’s Promising Prostate Cancer Study: A Market Game Changer?
Premium
Company Announcements
Astellas Pharma’s Promising Prostate Cancer Study: A Market Game Changer?
5M ago
ALPMF

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >